Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.
2.

Rapid detection of papillary thyroid carcinoma by fluorescence imaging using a γ-glutamyltranspeptidase-specific probe: a pilot study.

Hino R, Inoshita N, Yoshimoto T, Ogawa M, Miura D, Watanabe R, Watanabe K, Kamiya M, Urano Y.

Thyroid Res. 2018 Nov 21;11:16. doi: 10.1186/s13044-018-0060-y. eCollection 2018.

3.

Stromal tiny black dots, like "sugar-coated", of von Kossa stain is a diagnostic clue to hyalinizing trabecular tumor of the thyroid gland.

Hino R, Motoi N, Toda K, Ebina A, Yamada K, Higuchi M, Hirokawa M, Ishikawa Y.

Pathol Int. 2018 Mar;68(3):176-182. doi: 10.1111/pin.12638. Epub 2018 Jan 24.

PMID:
29368414
4.

Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.

Oishi N, Kondo T, Ebina A, Sato Y, Akaishi J, Hino R, Yamamoto N, Mochizuki K, Nakazawa T, Yokomichi H, Ito K, Ishikawa Y, Katoh R.

Mod Pathol. 2017 Nov;30(11):1527-1537. doi: 10.1038/modpathol.2017.75. Epub 2017 Jul 21.

5.

Development of an Activatable Fluorescent Probe for Prostate Cancer Imaging.

Yogo T, Umezawa K, Kamiya M, Hino R, Urano Y.

Bioconjug Chem. 2017 Aug 16;28(8):2069-2076. doi: 10.1021/acs.bioconjchem.7b00233. Epub 2017 Jul 26.

PMID:
28691803
6.

Brain edema with clasmatodendrosis complicating ataxia telangiectasia.

Shimoda K, Mimaki M, Fujino S, Takeuchi M, Hino R, Uozaki H, Hayashi M, Oka A, Mizuguchi M.

Brain Dev. 2017 Aug;39(7):629-632. doi: 10.1016/j.braindev.2017.02.007. Epub 2017 Mar 25.

PMID:
28351596
7.

Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer.

Abe H, Hino R, Fukayama M.

Virchows Arch. 2013 May;462(5):523-31. doi: 10.1007/s00428-013-1403-7. Epub 2013 Mar 28.

PMID:
23536282
8.

Enrichment of stem-like cell population comprises transformation ability of Epstein-Barr virus latent membrane protein 2A for non-transformed cells.

Nakaya T, Kikuchi Y, Kunita A, Ishikawa S, Matsusaka K, Hino R, Aburatani H, Fukayama M.

Virus Res. 2013 Jun;174(1-2):108-15. doi: 10.1016/j.virusres.2013.03.009. Epub 2013 Mar 22.

PMID:
23524324
9.

ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.

Abe H, Maeda D, Hino R, Otake Y, Isogai M, Ushiku AS, Matsusaka K, Kunita A, Ushiku T, Uozaki H, Tateishi Y, Hishima T, Iwasaki Y, Ishikawa S, Fukayama M.

Virchows Arch. 2012 Oct;461(4):367-77. doi: 10.1007/s00428-012-1303-2. Epub 2012 Aug 23.

PMID:
22915242
10.

SOX9 expression and its methylation status in gastric cancer.

Sun M, Uozaki H, Hino R, Kunita A, Shinozaki A, Ushiku T, Hibiya T, Takeshita K, Isogai M, Takada K, Fukayama M.

Virchows Arch. 2012 Mar;460(3):271-9. doi: 10.1007/s00428-012-1201-7. Epub 2012 Feb 14.

PMID:
22331131
11.

Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.

Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, Uozaki H, Seto Y, Takada K, Aburatani H, Fukayama M.

Cancer Res. 2011 Dec 1;71(23):7187-97. doi: 10.1158/0008-5472.CAN-11-1349. Epub 2011 Oct 11.

12.

Pleural cavity angiosarcoma arising in chronic expanding hematoma after pneumonectomy.

Miyazaki H, Goto A, Hino R, Ota S, Okudaira R, Murakawa T, Nakajima J, Fukayama M.

Hum Pathol. 2011 Oct;42(10):1576-9. doi: 10.1016/j.humpath.2010.06.019. Epub 2011 Apr 15.

PMID:
21497371
13.

Transcriptional factor typing with SOX2, HNF4aP1, and CDX2 closely relates to tumor invasion and Epstein-Barr virus status in gastric cancer.

Uozaki H, Barua RR, Minhua S, Ushiku T, Hino R, Shinozaki A, Sakatani T, Fukayama M.

Int J Clin Exp Pathol. 2011 Mar;4(3):230-40. Epub 2011 Mar 1.

14.

Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.

Morikawa T, Hino R, Uozaki H, Maeda D, Ushiku T, Shinozaki A, Sakatani T, Fukayama M.

Hum Pathol. 2010 Dec;41(12):1742-8. doi: 10.1016/j.humpath.2010.06.001. Epub 2010 Sep 9.

PMID:
20825972
15.

Downregulation of microRNA-200 in EBV-associated gastric carcinoma.

Shinozaki A, Sakatani T, Ushiku T, Hino R, Isogai M, Ishikawa S, Uozaki H, Takada K, Fukayama M.

Cancer Res. 2010 Jun 1;70(11):4719-27. doi: 10.1158/0008-5472.CAN-09-4620. Epub 2010 May 18.

16.

Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling.

Shinozaki A, Ushiku T, Morikawa T, Hino R, Sakatani T, Uozaki H, Fukayama M.

J Histochem Cytochem. 2009 Aug;57(8):775-85. doi: 10.1369/jhc.2009.953810. Epub 2009 Apr 27.

17.

Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.

Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M.

Cancer Res. 2009 Apr 1;69(7):2766-74. doi: 10.1158/0008-5472.CAN-08-3070.

18.

Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.

Fukayama M, Hino R, Uozaki H.

Cancer Sci. 2008 Sep;99(9):1726-33. doi: 10.1111/j.1349-7006.2008.00888.x. Epub 2008 Jul 4. Review.

19.

Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.

Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M.

Cancer Res. 2008 Mar 1;68(5):1427-35. doi: 10.1158/0008-5472.CAN-07-3027.

20.

p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.

Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, Rani BR, Sakuma K, Nagai H, Fukayama M.

Int J Cancer. 2007 Jan 1;120(1):60-6.

Supplemental Content

Loading ...
Support Center